VARICELLA-ZOSTER VIRUS-ANTIBODY AVIDITY AND IGG-SUBCLASS PATTERNS IN CHILDREN WITH RECURRENT CHICKENPOX

被引:47
作者
JUNKER, AK
TILLEY, P
机构
[1] UNIV BRITISH COLUMBIA, DEPT PEDIAT, VANCOUVER V6T 1W5, BC, CANADA
[2] UNIV BRITISH COLUMBIA, DEPT MED MICROBIOL, VANCOUVER, BC, CANADA
关键词
ANTIBODY AFFINITY; IMMUNE MEMORY; VARICELLA-ZOSTER VIRUS;
D O I
10.1002/jmv.1890430204
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The normal immune response after primary varicella-zoster virus (VZV) infection includes IgG subclass evolution to predominantly IgG1-type antibodies, and maturation from low to high avidity antibodies which are maintained for life. Twenty-three healthy and apparently immunocompetent children with a history of 2-5 episodes of chickenpox were studied after repeat disease. Serial sera were tested for VZV-IgG subclass patterns and VZV IgG and G-subclass antibody avidity by urea elution enzyme linked immunoassay (ELISA). Of 11 patients studied within 8 weeks of repeat chickenpox (Early Group), mean antibody avidity was significantly lower (31.3 +/- 26.81) than control (65.1 +/- 12.38) (P < .001). Seven had low avidity antibody (< 30 percent) and an abundance of IgG3 which was a pattern like primary chickenpox, and 2/11 had high avidity antibody characteristic of anamnestic responses. Early Group patients and 12 others studied over 8 weeks after repeat disease (Late Group) showed avidity maturation and attrition of IgG subclass antibodies other than IgG1. At least nine children failed to show VZV-specific secondary (memory) immune responses early in the course of repeat disease. It is possible that failure to maintain or evoke a secondary immune response could explain their susceptibility to repeat chickenpox. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 21 条
[1]  
ASANO Y, 1987, PEDIATRICS, V80, P933
[2]   SEVERITY OF VIREMIA AND CLINICAL FINDINGS IN CHILDREN WITH VARICELLA [J].
ASANO, Y ;
ITAKURA, N ;
KAJITA, Y ;
SUGA, S ;
YOSHIKAWA, T ;
YAZAKI, T ;
OZAKI, T ;
YAMANISHI, K ;
TAKAHASHI, M .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (06) :1095-1098
[3]   THE IMMUNOGENICITY OF THE OKA MERCK VARICELLA VACCINE IN RELATION TO INFECTIOUS VARICELLA-ZOSTER VIRUS AND RELATIVE VIRAL-ANTIGEN CONTENT [J].
BERGEN, RE ;
DIAZ, PS ;
ARVIN, AM .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) :1049-1054
[4]   WESTERN BLOT ANALYSIS OF ANTIBODY TO VARICELLA-ZOSTER VIRUS [J].
DUBEY, L ;
STEINBERG, SP ;
LARUSSA, P ;
OH, P ;
GERSHON, AA .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) :882-888
[5]   MEMORY T-CELLS ENHANCE THE EXPRESSION OF HIGH-AVIDITY NAIVE B-CELLS [J].
FRANCUS, T ;
FRANCUS, Y ;
SISKIND, GW .
CELLULAR IMMUNOLOGY, 1991, 134 (02) :520-527
[6]   VARICELLA VACCINE - THE AMERICAN EXPERIENCE [J].
GERSHON, AA ;
LARUSSA, P ;
HARDY, I ;
STEINBERG, S ;
SILVERSTEIN, S .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 :S63-S68
[7]   CLINICAL REINFECTION WITH VARICELLA-ZOSTER VIRUS [J].
GERSHON, AA ;
STEINBERG, SP ;
GELB, L .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (02) :137-142
[8]   B-CELL MEMORY IS SHORT-LIVED IN THE ABSENCE OF ANTIGEN [J].
GRAY, D ;
SKARVALL, H .
NATURE, 1988, 336 (6194) :70-73
[9]  
GRAY D, 1990, CURR TOP MICROBIOL, V159, pS1
[10]   A QUANTITATIVE RELATIONSHIP BETWEEN ANTIBODY-AFFINITY AND ANTIBODY AVIDITY [J].
GRISWOLD, WR .
IMMUNOLOGICAL INVESTIGATIONS, 1987, 16 (02) :97-106